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Abstract We have studied the mechanisms that regulate the
remodeling of the glycolytic, mitochondrial and structural
network of muscles of creatine kinase M (M-CK)/sarcomeric
mitochondrial creatine kinase (ScCKmit) knockout mice by
comparison of wild-type and mutant mRNA profiles on cDNA
arrays. The magnitudes of changes in mRNA levels were most
prominent in M-CK/ScCKmit (CK3=3) double mutants but did
never exceed those of previously observed changes in protein level
for any protein examined. In gastrocnemius of CK3=3 mice we
measured a 2.5-fold increase in mRNA level for mitochondrial
encoded cytochrome c oxidase (COX)-III which corresponds to
the increase in protein content. The level of the nuclear encoded
mRNAs for COX-IV, H+-ATP synthase-C, adenine nucleotide
translocator-1 and insulin-regulatable glucose transporter-4
showed a 1.5-fold increase, also in agreement with protein data.
In contrast, no concomitant up-regulation in mRNA and protein
content was detected for the mitochondrial inorganic phosphate-
carrier, voltage-dependent anion channel and certain glycolytic
enzymes. Our results reveal that regulation of transcript level
plays an important role, but it is not the only principle involved in
the remodeling of mitochondrial and cytosolic design of CK3=3
muscles. ß 2001 Federation of European Biochemical Soci-
eties. Published by Elsevier Science B.V. All rights reserved.
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1. Introduction
Muscle tissue has a high plasticity and is capable of re-
organizing its metabolic and structural features along with
internal and environmental needs [1,2]. Thus, dynamic regu-
lation of mRNA and protein expression is of fundamental
importance. Gene expression in muscle is known to respond
to chronic low-frequency stimulation, caloric restriction, hy-
perthyroidism, or feeding of metabolic inhibitors [3^6]. Also
genetic stress in cellular energy metabolism can evoke signi¢-
cant changes in muscle biogenesis [7]. Many of these responses
are thought to serve as adaptations to counteract the adverse
e¡ect of physiological challenge or gene mutation [1,7^9].
Previously, we have studied changes in the biogenesis of the
glycolytic, mitochondrial and structural network in muscles of
knockout mice that lack the creatine kinase (CK) isoenzyme
subunits sarcomeric mitochondrial creatine kinase (ScCKmit)
and muscle-speci¢c cytosolic creatine kinase (M-CK) [10^12].
By understanding the mechanisms that regulate this metabolic
and cytoarchitectural remodeling, one can gain insight into
the signaling systems that sense the physiological consequen-
ces of mutation and help to coordinate the response. Whether
these regulatory principles involve alterations in de novo syn-
thesis or altered turnover of gene products, or both, is not
known.
CKs (EC 2.7.3.2) are cytosolic and mitochondrial enzymes
that catalyze the reaction MgADP3+PCr23+HICr+
MgATP23. The CK/phosphocreatine (PCr) system balances
adenylates at cellular sites of energy production and consump-
tion by providing PCr as ‘temporal energy bu¡er’ and serving
as ‘high-energy phosphoryl shuttle’ [13,14]. Thus, the system
protects against e¡ects of ischemia and anoxia, and couples
mitochondrial oxidative phosphorylation (OXPHOS) and gly-
colysis to metabolic demand [15]. The composition and func-
tion of the CK circuit di¡er between di¡erent muscle types
and functional redundancy with other pathways for high-en-
ergy phosphoryl transfer, such as the adenylate kinase, the
nucleoside diphosphate kinase (NDPK), and the glycolytic
system has been demonstrated [13,16,17].
Using mRNA expression pro¢ling on cDNA arrays, the
transcriptional response of clusters of genes to a perturbation
in the cellular state can be measured [18]. In this study, we use
this technique to examine mutation and cell-type-dependent
changes in the levels of individual mRNAs and correlate our
¢ndings to previous data on the content of key-metabolic
enzymes in normal and CK-de¢cient muscles. The analysis
enabled us to assess the relative importance of transcript level
regulation in the response to metabolic stress induced by CK
de¢ciency.
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2. Materials and methods
2.1. Animals and RNA isolation
Animal breeding and housing conformed to the Guidelines for the
Care and Use of Laboratory Animals of the Dutch Council, with
approval of the Institutional Animal Care and Use Committee at
the University of Nijmegen. Individual gastrocnemius muscles from
each of four 100-day-old C57Bl/6 or 129/Ola female control mice, or
four female M-CK3=3 single and CK3=3 double knockout mice were
dissected and total RNA was prepared using the LiCl^urea method
[19]. Soleus muscles from these animals were combined in one sample
for RNA preparation. One additional set of RNA samples was pre-
pared from either pooled gastrocnemius or soleus muscles from four
100-day-old female mice (for each di¡erent genotype).
RNA preparations of the total gastrocnemius/plantaris/soleus
(GPS) complex and liver of female C57Bl/6 and CK3=3 animals of
17 and 100 days of age (two animals of each strain per age class) were
used to study developmental e¡ects on mitochondrial and nuclear
gene expression.
2.2. cDNA probe synthesis
For synthesis of mixed cDNA probe, 2 Wg of total RNA was re-
verse transcribed for 90 min at 42‡C in a mixture containing 100 ng/Wl
oligo(dT) (Eurogentech, Seraing, Belgium), 0.5 mM d(A,T,G)TP,
4 WM dCTP, 5 mM DTT, 30 U RNAse Out, 250 U Superscript II
(Life Technologies, Breda, The Netherlands) and 75 WCi [K-32P]dCTP
(3000 Ci/mmol, Amersham Pharmacia, Roosendaal, The Netherlands)
in a ¢nal volume of 20 Wl (in duplicate). The quantity of 32P-labeled
total cDNA was assessed after puri¢cation over a Sephadex G-50
column (Amersham Pharmacia). cDNA length distribution was rou-
tinely monitored by electrophoresis on agarose gels. Before hybridi-
zation, the cDNA was treated with 20 Wg/ml RNAse A in TES bu¡er
[20] and diluted to 0.8^2.4U106 cpm/ml Church hybridization bu¡er
[21]. Marker probe was generated by random primed synthesis of a
1-kb mouse insulin-regulatable aminopeptidase vp165 ds cDNA tem-
plate. Speci¢c activities of di¡erent cDNA probe preparations ranged
between 1 and 10U106 cpm/Wg.
2.3. cDNAs and EST collections
Our collection of cDNA and expressed sequence tag (EST) clones
comprises a selection of 134 di¡erent mouse DNA sequences for gly-
colytic enzymes, mitochondrial enzymes and transporters, fatty acid
metabolism enzymes, muscle regulatory factors, proteins active in
Ca2 signaling, glucose transport, tissue oxygenation as well as cyto-
skeletal components and transcription factors. Detailed information
on the ESTs and construction of the cDNAs is available at
www.ncmls.kun.nl/celbio. Plasmid DNAs were grown in Escherichia
coli HB101, DH10B, DH12S, AG1 and SOLR host cells, isolated, and
puri¢ed on silica-gel membranes using the Qiagen miniprep procedure
(Qiagen, Hilden, Germany).
2.4. Preparation of gridded cDNA arrays on membranes
Plasmid DNAs, diluted at 0.25 Wg/Wl in 10 mM Tris^HCl/5 mM
EDTA supplemented with sucrose (1.5%) and cresol red (0.025%),
were gridded on Hybond N membranes (sized 11U3 cm; Amersham
Pharmacia). Empty plasmids served as negative controls. Macroarrays
were generated using a home-built arrayer (see http://cmgm.stan-
ford.edu/pbrown/mguide/index.html), with some modi¢cations from
the Brown group. The printhead contained 12 adjustable quilted
pens (custom made) with the width of a 384-wells plate (11 cm).
The machine was programmed to yield arrays on nylon ¢lters with
duplicate spot patterns of each cDNA. Speed of movements of the
printhead combined with the adjustment of the pens set the delivered
amount of DNA on the ¢lter to 60^80 nl per spot (15^20 ng). With
spot sizes of 700^800 Wm and a large heart-to-heart distance (3 mm)
32P can be used without the risk of overlapping signals.
Membrane-bound DNAs were denatured in 0.5 N NaOH/1.5 M
NaCl, renatured in 0.25 N HCl, and washed in 50 mM phosphate
bu¡er pH 7.2, before the DNA was UV cross-linked at 2 mJ/cm2
(Stratalinker, Stratagene, La Jolla, CA, USA). Membranes were
pre-hybridized overnight at 65‡C in Church bu¡er [21] supplemented
with 5UDenhart’s reagent [20] and 100 Wg/ml single-stranded herring
sperm DNA (Boehringer Mannheim, Germany).
2.5. Hybridization, washing and autoradiography
Arrays were hybridized for 4 days at 65‡C to the cDNA probe
mixture in 5 ml Church hybridization bu¡er, supplemented with
90 000 cpm of aminopeptidase pv165 cDNA marker probe. Subse-
quently, the arrays were washed to a ¢nal stringency of 0.1USSC/
0.1% SDS at 68‡C. Signals were captured and analyzed on a Bio-Rad
GS 363 Imaging system (Bio-Rad, Hercules, CA, USA) after an ex-
posure period of 30 min to 96 h. Signal intensity was expressed as the
mean cpm of the duplicate spots (Fig. 1A) minus the intensity of the
empty vector. Values at least 2-fold above background were collected
at the maximum exposure time. Problems with signal saturation were
avoided by determining signal intensities at shorter exposure, after
which all values were normalized for exposure time.
2.6. Analysis of hybridization results
All values for signal intensities were divided by the value for the
mean marker signal intensity. Based on the results of these initial
analyses, a designated subset of genes was identi¢ed for which no
up- or down-regulation was evident. Signal intensities for these
cDNAs were subsequently used for normalization [22].
2.7. Quantitative Western blot
Total protein extracts were prepared from colateral GPS complexes
of C57Bl/6 and CK3=3 mice used for RNA analysis. Preparation of
these extracts and semi-quantitative Western blots were performed as
described by de Groof et al. [12].
2.8. Statistical analysis
We used a Student’s t-test for comparison between wild-type, M-
CK3=3 and CK3=3 gastrocnemius muscles (four individual samples,
plus pooled sample: n = 5). Results were considered signi¢cant when
P6 0.05 compared to either wild-type strain (C57Bl/6 and 129/Ola),
unless stated otherwise. No statistical tests were applied to soleus
data, since we used n = 2 pooled samples.
3. Results
In order to correlate known changes in protein levels in
muscles of CK-de¢cient animals to changes in corresponding
mRNA levels, a specially designed array with 134 di¡erent
cDNAs/ESTs was used. Prior knowledge on gene function,
cell-type-speci¢c distribution, isoenzyme expression, and tran-
script abundance was used in the selection of cDNAs and
ESTs for the array. Based on the observation that there was
only a 2- to 4-fold change in the level of mitochondrial and
glycolytic proteins in gastrocnemius of mice with M-CK or
combined M-CK/ScCKmit de¢ciency [12], we expected that
also the corresponding mRNA levels would vary within rather
narrow margins. Therefore, we decided to refrain from use of
cDNA ampli¢cation procedures commonly used for high-den-
sity microarray hybridization [23].
3.1. mRNA pro¢le of fast-twitch gastrocnemius is changed by
CK absence
A representative array comparison for mRNAs from gas-
trocnemius muscles of C57Bl/6 and CK3=3 mice is shown in
Fig. 1A. As anticipated, we still detected residual ScCKmit
and M-CK mRNA in CK3=3 mice in our assay. For both
genes, the gene targeting strategy used led to the formation of
aberrant mRNAs and complete loss of M-CK and ScCKmit
enzyme coding capacity as demonstrated earlier [10,11].
Normalized pro¢ling data for fast-twitch gastrocnemius of
wild-type and CK3=3 mice are depicted in the scatter graph of
Fig. 1B. Strikingly, ¢ve out of eight a¡ected signals in gastroc-
nemius muscle represent mRNAs encoding mitochondrial
proteins. Mitochondrial DNA encoded cytochrome c oxidase
(COX)-III showed a 2.5-fold up-regulation. Its presence in the
cDNA mixture results from annealing of oligo(dT) to A-rich
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stretches in the COX-III RNA. Nuclear DNA encoded
mRNAs for COX-IV, H-ATP synthase-C, adenine nucleo-
tide translocator-1 (ANT1), isocitrate dehydrogenase (all mi-
tochondrial), glyceraldehyde-3-phosphate dehydrogenase
(GAPDH), NDPK-M2 and insulin-regulatable glucose trans-
porter (GLUT4) were 1.3- to 1.6-fold increased in CK3=3
muscles. No signi¢cant e¡ects were seen for these mRNAs
in M-CK single mutant mice, except for the COX-III and
GAPDH signals. Quantitative measurements on single RNA
preparations and on pooled gastrocnemius muscle samples
yielded identical results (not shown), data are therefore pre-
sented in a combined fashion in Table 1.
Because all values ranged within 96^248% of those in
C57Bl/6 wild-type mice, we decided to analyze mRNA quan-
tities also by inter-comparison in an ‘order of signal intensity’
plot (Fig. 1C), which renders comparison independent of the
normalization procedure used. One caveat with this approach
is that the magnitude of the shift in ranking position will be
rather small for (the few) transcripts with a relatively high
expression level (such as COX-III), and rather large for tran-
scripts with a low expression level (where many transcripts
cluster together). Consistent increases in signal intensity rank-
ing position were again observed for all genes mentioned in
Table 1. In addition, the uncoupling protein-2 (UCP2) mRNA
level showed a drastic shift in ranking order. However, this
observation may be non-signi¢cant as the shift was based on a
decrease of only 35% at low signal intensity (P = 0.12; n = 4
compared to C57Bl/6 and 129/Ola). Also the UCP3 transcript
level showed a 33% decrease, but with substantial di¡erences
between wild-type strains C57Bl/6 and 129/Ola (not shown).
E¡ects of genetic background variation can therefore not be
fully excluded for this latter mRNA.
3.2. mRNA pro¢le of slow-twitch soleus is changed by
CK absence
We have previously shown that the nature and magnitude
of the compensatory adaptations in muscles of CK-de¢cient
mice are strongly cell-type dependent [10^12]. Changes in
mRNA transcript pro¢les of M-CK3=3, CK3=3, C57Bl/6
and 129/Ola mice from pooled slow-twitch soleus RNA (two
sets) were therefore also determined. Although values for a
conspicuous high number of signals were closer to back-
ground than in the gastrocnemius arrays (not shown), again
several ESTs/cDNAs displaying a 1.2- to 2.5-fold change in
signal intensity were identi¢ed (Table 2), including COX-III,
nuclear encoded mitochondrial transcripts and GLUT4. Con-
sistently, changes were only evident in CK3=3 and not in M-
CK3=3 soleus, the only notable exception being ventricular
myosin light chain-2 (MLC2v) mRNA which displayed a
30% and 80% increase in these mutant muscles, respectively.
Interestingly, converse changes in SR/ER calcium ATPase-1
(SERCA1; 345% decrease) and SERCA2 (+33% increase)
mRNA levels resulted in a relative shift in favor of SERCA2
expression in CK3=3 soleus.
Fig. 1. A: 32P images of arrays from C57Bl/6 wild-type and CK3=3
gastrocnemius muscles. B9, ScCKmit; B11, M-CK; B20, actin; B28,
COX-III; C2, COX-IV; C3, isocitrate dehydrogenase; C32,
GLUT4; D3, H-ATP synthase-C. B: Scatter graph representation
of array data of C57Bl/6 (x-axis) and CK3=3 gastrocnemius (n = 4).
Axes show signal intensities after normalization. The dark solid line
represents equal expression levels in wild-type and CK3=3 samples,
the gray solid line marks 40% di¡erence in signal intensity. C: Or-
der of appearance representation of comparative data of C57Bl/6
(x-axis) and CK3=3 gastrocnemius (n = 4). UCP3 (16,3); NDPK-M2
(19,39); UCP2 (40,22); GADPH (61,72); GLUT4 (62,73); H-ATP
synthase-C (67,75); isocitrate dehydrogenase (70,74); COX-IV
(75,77); COX-III (81,84); ANT1 (85,86).
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3.3. Developmental timing of adaptive changes in muscle
mRNA pro¢le
CK isoenzyme expression pro¢les in normal muscles change
during maturation and growth to adulthood [13]. Adaptations
in mRNA levels in response to CK de¢ciency may therefore
have a £exible character during the ¢rst months of life. Com-
parison of RNA expression levels between whole GPS muscles
of CK3=3 and wild-type animals at 17 and 100 days of age
(Table 3) demonstrated that up-regulation of mRNAs encod-
ing mitochondrial proteins, MLC2v and GLUT4 is already
evident early in life. Strikingly, at 17 days we found an in-
crease in mRNA content for voltage-dependent anion chan-
nel-3 (VDAC3), and the inorganic phosphate (Pi)-carrier
and 2-oxoglutarate/malate carrier. Increase in mRNA con-
tent for these proteins was not seen in animals at 100 days
of age.
3.4. Are organ-related e¡ects involved in CK-related changes in
mRNA pro¢le?
To ascertain that changes in mRNA pro¢le are not an e¡ect
of altered endocrine signaling or whole-body metabolism, and
are con¢ned to CK-de¢cient muscles only, we also performed
mRNA array analysis of liver from 100-day-old CK3=3 and
wild-type mice. Liver was chosen because it is central in
whole-body energy metabolism [14], but should not be af-
fected by ‘internal’ metabolic stress as CKs are not expressed
in this organ. Comparison of mutant and control livers
yielded no signi¢cant di¡erences (Fig. 2A; quantitative data
not shown). Unlike in muscle, also the balance in expression
levels for COX-IV and COX-III, representatives for the nu-
clear and mitochondrial transcript populations, respectively,
was essentially unchanged (Fig. 2B).
3.5. Linear relationship between changes in mRNA and
protein levels?
Relative changes in protein (values taken from [12]) and
mRNA content in CK-de¢cient gastrocnemius are compared
in Tables 1 and 2. There is simultaneous change in protein
and mRNA levels for ANT, COX-IV (see below) and
GLUT4, but not for VDAC, and Pi-carrier. To analyze this
phenomenon in more detail we assessed the relationship be-
tween mitochondrial COX-III and nuclear COX-IV mRNA
and protein levels in greater detail. Semi-quantitative Western
blot analysis of the protein content in two wild-type and two
mutant GPS muscles (Fig. 2C) showed a 2.6-fold up-regula-
tion of COX-III protein content, in line with the 2.5-fold
increase in the level of COX-III mRNA in the CK3=3 mouse.
By contrast, no strict coupling between the increase in COX-
IV protein and mRNA content was seen (2.6-fold vs. 1.5-fold
up-regulation, respectively).
4. Discussion
We used conventional mRNA pro¢ling on cDNA arrays to
obtain insight into mechanisms that play a role in sensing of ^
and the response to ^ metabolic stress in the CK-mediated
high-energy phosphoryl shuttle. Earlier our group had already
uncovered important functional and structural di¡erences be-
tween M-CK3=3, CK3=3 and wild-type muscles [10,11,15],
most of which were associated with rather subtle changes in
the level of a diverse series of mitochondrial, cytoarchitectural
and glycolytic proteins [12]. Based on these ¢ndings we have
postulated that most ^ if not all ^ of these changes may in fact
have a compensatory character, serving to ameliorate the ad-
verse physiological e¡ects of gene ablation [10,11]. Similar
Table 1
RNA expression changes in gastrocnemius
EST/cDNA C57Bl/6 M-CK3=3 CK3=3 129/Ola
RNA Proteina RNA Proteina RNA Proteina RNA Proteina
COX-III 100 þ 5.6 nd 142 þ 5.7*;# nd 248 þ 37*;3 nd 123 þ 6.52 nd
Isocitrate dehydrogenase 100 þ 8.7 nd 129 þ 16 nd 145 þ 112;4 nd 103 þ 9.9 nd
H-ATP synthase-C 100 þ 7.3 nd 127 þ 12V nd 166 þ 202;4 nd 101 þ 14 nd
COX-IV 100 þ 10 100 116 þ 13 197 134 þ 8.32;4 427 96 þ 11 121
ANT1 100 þ 1.2 100 107 þ 6.4 181 133 þ 7.2*;4 251 98 þ 11 146
GAPDH 100 þ 8.2 nd 152 þ 11*;# nd 157 þ 192;# nd 104 þ 19 nd
GLUT4 100 þ 8.7 100 101 þ 5.6 160 161 þ 192;4 204 116 þ 5.6 161
NDPK-M2 100 þ 6.0 nd 113 þ 10 nd 158 þ 12* nd 126 þ 14 nd
Values represent percentage þ S.E.M. (n = 5). *P6 0.1 vs. C57Bl/6; 2P6 0.05 vs. C57Bl/6; VP6 0.10 vs. C57Bl/6; 3P6 0.01 vs. 129/Ola;
4P6 0.05 vs. 129/Ola; #P6 0.10 vs. 129/Ola. nd, not done.
aData from de Groof et al. [12].
Table 2
RNA expression changes in soleus (mean values of two sets of pooled samples)
EST/cDNA C57Bl/6 M-CK3=3 CK3=3 129/Ola
RNA Proteina RNA Proteina RNA Proteina RNA Proteina
COX-III 100 nd 97 nd 247 nd 123 nd
Isocitrate dehydrogenase 100 nd 73 nd 117 nd 87 nd
H-ATP synthase-C 100 nd 84 nd 125 nd 94 nd
COX-IV 100 100 92 105 123 182 101 91
ANT1 100 100 91 89 138 137 91 95
GLUT4 100 100 101 145 136 155 106 137
MLC2v 100 nd 132 nd 180 nd 98 nd
SERCA1 100 nd 89 nd 55 nd 105 nd
SERCA2 100 nd 125 nd 133 nd 105 nd
nd, not done.
aData from de Groof et al. [12].
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compensatory remodeling, involving an increased mitochon-
drial density or alteration in O2 di¡usion pathway(s), has
meanwhile been observed in ANT1 [7,24] and myoglobin
[8,9,25] knockout mice and is a normal response to physio-
logical challenge [1].
We demonstrate here that part of this plasticity is regulated
by adaptation in the steady state level of mRNAs. As might
have been anticipated, the magnitudes of changes in mRNA
levels did never exceed those of the changes in protein level.
Moreover, for most mRNAs the e¡ects are signi¢cantly more
prominent in CK3=3 than in M-CK3=3 mice, in accordance
with the protein ¢ndings. For COX-IV, ANT, and GLUT4,
changes in mRNA and protein content were signi¢cantly cor-
related, albeit not in a 1:1 relationship. Strikingly, although
Pi-carrier and VDAC protein content were signi¢cantly (2- to
4-fold) increased, we did not detect changes in mRNA level
for these proteins in 100-day-old CK3=3 gastrocnemius. Only
in 17-day-old GPS complex we did see a modest (1.5-fold)
increase in the level of mRNAs for these proteins. Moreover,
with the exception of GAPDH mRNA, we did not ¢nd an
e¡ect on the expression levels of glycolytic mRNAs like those
for lactate dehydrogenase, aldolase or pyruvate kinase-M.
Earlier we demonstrated that lactate dehydrogenase (and pos-
sibly aldolase) undergoes an isoenzyme shift which is most
notable in soleus of CK3=3 animals [12]. We may therefore
have to use isoform-speci¢c probes in future cDNA array
analyses to identify any e¡ects at the transcript level for these
proteins.
For COX-IV mRNA we see that a moderate (34%) increase
in mRNA level still allows a greater than 2-fold increase in
protein product in CK3=3 mice. Between changes in COX-III
mRNA and protein content, a better correlation was found.
Similar discrepancies between responses in nuclear and mito-
chondrial transcripts after electrical stimulation in muscle
were reported by Williams et al. [26]. The cellular concentra-
tion of mitochondrial COX mRNAs (COX-I, -II, -III) is
largely determined by mtDNA copy number, and is higher
than that of nuclear encoded COX mRNAs (COX-IV) [27].
Both transcriptional and posttranscriptional regulatory prin-
ciples have been proposed to explain how ultimately equimo-
lar ratios of translation products assemble as subunits into the
COX holoenzyme [28], and how protein expression levels of
OXPHOS genes are adjusted to changes in energy require-
ments [29,30]. Taken together, our data suggest that both
transcriptional and translational control of nuclear encoded
mitochondrial transcripts are involved in the remodeling of
muscle in our CK mutants, whereas mitochondrial encoded
genes are mainly controlled by transcriptional regulation.
We found no e¡ects on steady state levels of the mRNAs
for muscle transcription factors MyoD and MRF4, whereas
myogenin and Myf5 mRNAs were not reliably detectable
(data not shown). Also the mitochondrial transcription factor
A (Tfam) showed no change in mRNA level, whereas NRF1,
NRF2a and NRF2b could not be quanti¢ed reliably. For
calcineurin, a key regulatory factor linking calcium homeo-
stasis to gene expression, we observed no change in mRNA
levels. Of course, our results do not exclude the possibility
that these factors themselves do have an active role in regu-
Table 3
RNA expression changes in GPS complexes of 17-day-old and 100-






Isocitrate dehydrogenase 148 154







2-oxoglutarate/malate carrier 145 118
MLC2v 199 129
a17 days: results of pairwise comparison of two pooled C57Bl/6 and
two pooled CK3=3 GPS complexes.
b100 days: results of comparisons between two C57Bl/6 and two
CK3=3 GPS complexes.
Fig. 2. A: Representative arrays from C57Bl/6 and CK3=3 liver
(100 days) and C57Bl/6 soleus muscle. A6, M-CK; A7, adenylate
kinase 1; A8, ScCKmit; A12, fatty acid synthase; A27, ANT2;
A33, SERCA1; A39, COX-IV; A41, COX-III; B13, hexokinase 1;
B45, actin. B: COX-III and COX-IV mRNA expression levels in
C57Bl/6 (white bars) and CK3=3 liver and GPS muscle of two 100-
day-old mice. Error bars indicate standard error of the mean
(S.E.M.) of the signals in two hybridization experiments. The ex-
pression level of COX-IV in C57Bl/6 liver and GPS muscle was ar-
bitrarily set to 1 for comparison. C: Quantitative Western blot for
COX-III (22 kDa) and COX-IV (17 kDa). Two wild-type samples
(WT: 1-fold and 2-fold protein concentration) were loaded to facili-
tate densitometric analysis of band intensities (WT = 100%).
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lating the phenotypic adaptations, but e¡ects at the transcript
level are not evident.
Whatever the regulatory principle(s) involved, our pro¢ling
data give further support to the contention that the mRNA
and protein changes have a compensatory role. The increase
in mRNA content for several mitochondrial proteins could
re£ect the increased mitochondrial density and greater need
for increased mitochondrial ATP production [11]. A further
compensatory mechanism might involve the mitochondrial
proton homeostasis, re£ected in the 1.6-fold up-regulation of
H-ATP synthase-C and 0.65-fold down-regulation of UCP2
(and UCP3). Although further study is necessary, we envisage
a model where proton leak via UCP is prohibited and more
protons enter the mitochondrion via the H-ATP synthase
complex, thereby providing greater e⁄ciency in ATP produc-
tion [31]. The increase in MLC2v expression could re£ect a
changed isoenzyme composition of MLC2 (a possible isoen-
zyme shift from MLC2f to MLC2v), leading to altered energy
consumption in the contractile apparatus.
In conclusion, our array data show that the observed phe-
notypic adaptations in CK-de¢cient mice are caused by a
concerted remodeling of di¡erent muscle characteristics, with
an important role for regulation of transcript level.
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